10 Mar 2020 --- A cannabinoid called tetrahydrocannabivarin (THCV) could provide a novel avenue of research in diabetes and weight management thanks to its appetite-suppressing characteristics. This is according to Dutch Passion Seed Company, which has delivered its first batch of feminized THCV seed strains, which contain 6 to 8 percent THCV, to licensed producers worldwide.
